Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of BXPHF will - over the next 2 Weeks and hit - by . In that time frame, BXPHF's share price is expected to range between - and -.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No Data | |||||||||||||||||||
BXPHF shares remained flat 0 in Wednesday, August 19, 2026's trading session, starting and closing at a previous close of $0.02 to move at $0.02. The stock demonstrated notable intraday movement (see BXPHF's key stats for a full breakdown), fluctuating between $0.02 and $0.02, a 0 trading range. While recent weeks have seen some volatility, BXPHF has managed to secure a -25.33% drop over the past 2 weeks. The neutral price movement was accompanied by increased trading volume, with approximately 45K shares changing hands, 33.89K more than the previous session. This amounted to $756.00 in total market activity.
Will BXPHF Continue Its Trend?
According to analyst ratings and projections for BXPHF, Botanix Pharmaceuticals Limited shares are anticipated to remain stable by -, potentially reaching - per share by January 1, 1970. Short-term technical indicators for BXPHF currently suggest a bearish sentiment. This aligns with the stock's recent performance, as it has recorded 18 negative trading days within the past 30 sessions. Based on the BXPHF stock forecast, now is not the best time to buy BXPHF stock because its current trading price is - our predicted value, hinting at a possible . For deeper insights, view our sentiment analysis on BXPHF covering social and institutional perspectives.
BXPHF Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into BXPHF's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 45.56% to 48.14%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 45.97%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 45.21%, maintains a neutral outlook for the long term. Insights into BXPHF's shareholder base show how institutional investors are positioning themselves during these momentum shifts

